HSIC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Henry Schein Inc.

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.0 billion in 2019, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.
CEO
Stanley Bergman
Employees
19000
Headquarters

135 Duryea Rd
Melville, New York 11747-3834
Phone: 16318435500
www.henryschein.com

News

Henry Schein Stock: Long-Term Value Selling Cheap, But Could Get More Attractive (HSIC)
Nov 16, 2022 16:25pm

Henry Schein meets the need for continued growth projected into the future. See why we recommend a hold on HSIC stock.


Source:Seeking Alpha
Henry Schein to Present at Upcoming Investor Conferences
Nov 09, 2022 11:30am

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences: Piper Sandler’s 34th Annual Healthcare Conference at the Lotte New York Palace on November 30, 2022, at 9:00 a.m. Eastern time. Evercore ISI HealthCONx Virtual Conference


Source:Wallstreet:Online
Henry Schein, Inc. (HSIC) CEO Stanley Bergman on Q3 2022 Results - Earnings Call Transcript
Nov 01, 2022 19:50pm

Henry Schein, Inc. (NASDAQ:NASDAQ:HSIC) Q3 2022 Earnings Conference Call November 01, 2022 10:00 AM ET Company Participants Graham Stanley - VP of IR & Strategic Financial Project…


Source:Seeking Alpha
Henry Schein, Inc. 2022 Q3 - Results - Earnings Call Presentation (NASDAQ:HSIC)
Nov 01, 2022 14:26pm

The following slide deck was published by Henry Schein, Inc.


Source:Seeking Alpha
Henry Schein: Q3 Earnings Insights
Nov 01, 2022 11:28am

Henry Schein (NASDAQ: HSIC ) reported its Q3 earnings results on Tuesday, November 1, 2022 at 06:30 AM. Here''s what investors need to know about the announcement. Earnings Henry Schein beat estimated earnings by 0.88%, reporting an EPS of $1.15 versus … Full story available on Benzinga.com


Source:Benzinga
ROUNDUP: Henry Schein Q3 Profit Declines, But Above View
Nov 01, 2022 11:27am

MELVILLE (dpa-AFX) - (Adds Outlook)Henry Schein Inc. (HSIC) announced a profit for third quarter that decreased from last year but beat the Street estimates.The company''s bottom line totaled $150 …


Source:Finanz Nachrichten
Henry Schein Inc. Q3 Profit Decreases, but beats estimates
Nov 01, 2022 11:21am

MELVILLE (dpa-AFX) - Henry Schein Inc. (HSIC) announced a profit for third quarter that decreased from last year but beat the Street estimates.The company''s bottom line totaled $150 million, or $1…


Source:Finanz Nachrichten
Henry Schein Non-GAAP EPS of $1.15 beats by $0.01, revenue of $3.1B misses by $90M (NASDAQ:HSIC)
Nov 01, 2022 10:34am

Henry Schein press release (HSIC): Q3 Non-GAAP EPS of $1.15 beats by $0.01.Revenue of $3.1B (-2.2% Y/Y) misses by $90M.Full-year 2022 non-GAAP diluted EPS guidance of $4.79 to $4.87 vs


Source:Seeking Alpha
Henry Schein Reports Record Non-GAAP Third-Quarter 2022 Diluted EPS Financial Results
Nov 01, 2022 10:30am

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein reports record non-GAAP third-quarter 2022 diluted EPS financial results.


Source:Business Wire
Henry Schein Q3 2022 Earnings Preview (NASDAQ:HSIC)
Oct 31, 2022 16:13pm

Henry Schein (HSIC) is scheduled to announce Q3 earnings results on Tuesday, November 1st, before market open.The consensus EPS Estimate is $1.14 (+3.6% Y/Y) and the consensus…


Source:Seeking Alpha
Henry Schein to Present at Investor Conferences in November
Oct 20, 2022 10:30am


Source:Kwhen Finance
E-Prescribing Market to Witness Huge Growth by 2028 : Cerner, Athenahealth, DrFirst
Oct 04, 2022 15:07pm

New Jersey, NJ -- ( SBWIRE ) -- 10/04/2022 -- The latest independent research document on E-prescribing examine investment in Market. It describes how companies deploying these technologies across various industry verticals aim to explore its potential to become a major business disrupter. The E-prescribing study eludes very useful reviews & strategic assessment including the generic market trends, emerging technologies, industry drivers, challenges, regulatory policies that propel the market growth, along with major players profile and strategies. This version of E-prescribing market report advocates analysis of Henry Schein, Cerner, Athenahealth, DrFirst, HealthFusion, Practice Fusion, Surescripts, Allscripts Healthcare, Aprima Medical Software & Relayhealth. Get Free Sample Pages of E-prescribing Market Study Now @: https://www.htfmarketreport.com/sample-report/4150114-e-prescribing-market-2 As E-prescribing research and application [Hospitals, Clinic] continues to expand in scope, the market will see deeper integration and application of more technologies in the future.


Source:SBWire